Pr François Ghiringhelli

Spécialité

Oncologue médical, expert digestif

Hôpital

Centre Georges-François Leclerc (Dijon)

Derniers articles

• Cancer-associated fibroblasts and their prognostic role in colorectal cancer: review and meta-analysis. (10 déc. 2025)
• Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial. (1 déc. 2025)
• Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer. (21 nov. 2025)
• Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite Stable Colorectal Cancer. (6 nov. 2025)
• Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study. (30 oct. 2025)